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Abstract
Background: Thymic involution is thought to be an important factor of age related immunodeficiency. Understanding
the molecular mechanisms of human thymic senescence may lead to the discovery of novel therapeutic approaches
aimed at the reestablishment of central and peripheral T cell repertoire.
Results: As an initial approach, here we report that the decline of human thymic FOXN1 transcription correlates with
age, while other genes, DLL1, DLL4 and WNT4, essential for thymopoiesis, are constitutively transcribed. Using a human
thymic epithelial cell line (hTEC), we show that FOXN1 expression is refractory to signals that induce FOXN1
transcription in primary 3D culture conditions and by stimulation of the canonical WNT signaling pathway.
Blockage of FOXN1 induceability in the hTEC line may be mediated by an epigenetic mechanism, the CpG
methylation of the FOXN1 gene.
Conclusion: We showed a suppression of FOXN1 transcription both in cultured human thymic epithelial cells
and in the aging thymus. We hypothesize that the underlying mechanism may be associated with changes of
the DNA methylation state of the FOXN1 gene.
Background
In human, the thymus-derived naïve T cell repertoire,
capable to exert effective protection to foreign antigens,
is established during early embryonic life and it reaches
maximal size in childhood [1, 2], subsequently, as anti-
gen specific T cells are generated, the naïve T cell pool
is gradually depleted. Thus, the limited naïve T-cell rep-
ertoire in elderly individuals is a major contributor to
age-related immunodeficiency, a frequent cause of
death [3, 4]. The immune compromised status results
in the lack of effective immune response against patho-
genic microrganisms and malignant cells. Because age
related immunodeficiency is often life limiting as the
cause of frequent nosocomial infections of the elderly,
and because current treatment is insufficient, moreover
it represents a significant medico-economic burden [5],
there is a strong interest to develop effective and eco-
nomically sound therapies. One possible strategy is the
restoration of the naïve T cell repertoire via therapeutic
regeneration of thymic activity.
Bone marrow derived stem cells migrate to the thymus
where they proliferate and differentiate to T cell receptor
(TCR) expressing T cells while their progeny centripet-
ally migrate in, and eventually exit the organ. Accord-
ingly, the recent emigrant naïve T cells permanently
contribute to the peripheral T cell to maintain TCR
repertoire diversity, and, at least in part, age related
immunodeficiency is the result of the decline of naïve
emigrant T cell production [6]. Intrathymic T cell devel-
opment is orchestrated by the microenvironment, a
meshwork composed of stromal cells, such as dendritic
cells, fibroblasts, macrophages and thymic epithelial cells
(TEC), as well as by the extracellular matrix (ECM) mol-
ecules, which provide a unique three-dimensional envir-
onment [7]. The thymic stromal cells are distributed
within the thymic epithelial space, which is divided into
two main compartments, cortex and medulla [8, 9]. In
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the cortical and medullary microenvironments, TEC
interact with developing thymocytes via cell surface re-
ceptors, the production of ECM molecules, cytokines,
chemokines and growth factors [10]. Thymic epithelial
cells express (i) notch ligands which direct and restrict
the bone marrow precursors to the T cell differentiation
program [11] and (ii) self-antigen filled major histocom-
patibilty complex molecules (MHC) which serve as sub-
strates for TCR repertoire selection [12].
In humans, as the thymus ages, thymic epithelial mesh
is gradually replaced by adipose tissue. The process is
thought to start at the first year of life and continues dur-
ing aging [8, 13], being accompanied by a decreasing
export of naive T cells [14]. The underlying molecular
mechanisms responsible for the impairment of thymopoi-
esis in the aging thymus remains unclear. One possibility
is that intrinsic mechanisms related to TEC physiology are
impaired in old individuals, since bone marrow precursors
from old animals are able to colonize the thymus [15]. In
fact, some studies showed that TEC proliferation is lower
in old animals and it was also demonstrated that aging
mice have higher percentage of apoptotic and senescent
TECs [15, 16].
Studies in rodent models pointed out that the tran-
scriptional factor forkhead box protein N1 (FOXN1)
is both necessary and seemingly sufficient to induce
differentiation of functional TEC [17, 18]. FOXN1 ap-
pears on day 11 during mouse embryonic development,
the sixth week of gestation in humans, and induces the
thymic organogenesis program presumably under the
control of WNT family of glycoproteins, namely, by
WNT-4 [2, 19, 20]. In a model with inducible Cre medi-
ated deletion of an SV40 driven transgenic hypomorphic
Foxn1 allele, it has been demonstrated, that FOXN1 in
TEC induces the expression of MHC II, CD40, PAX1,
cathepsin-L, the chemokine CCL25 and the NOTCH
ligand Delta-like 4 (DLL4), thus highlighting its orches-
trating role in T cell maturation [21]. The lack of FOXN1
in mice and rats results in the absence or the incomplete
development of TEC and the thymic epithelial mesh, com-
bined with severe immunodeficiency known as the nude
phenotype [22]. Nude mice carry a single base pair dele-
tion at exon 3 of the Foxn1 gene, which results in aberrant
protein production, lacking the DNA-binding and the
transcription activation domains, necessary for FOXN1
protein function [23, 24]. Similar phenotype was found in
human, carrying a rare non-sense mutation at the residue
255 of the FOXN1 protein, resulting from a single base
substitution in exon 5 of the FOXN1 gene [25]. Recently,
Bredenkamp and co-workers showed that mouse embry-
onic fibroblasts transfected with inducible Foxn1 transdif-
ferentiated to functional TECs upon induction [18]. These
Foxn1 induced TECs support T cell development in vitro
and in vivo. The data clearly demonstrate the central role
of FOXN1 in thymic epithelial function and organogenesis.
Murine models showed a decrease on Foxn1 expression in
aged thymus [26, 27]. Others found that the decline of
Foxn1 expression results in a decrease of thymus cellular-
ity and function, compared to normal aged murine thymus
[28, 29]. In contrast, thymus from aged mice, with high
transgenic Foxn1 levels, presented morphology and T cell
maturation similar to the thymus of young mice [30]. In
addition, it was demonstrated that induction on Foxn1
expression in a murine aging model was able to restore
thymic architecture and T cell export, similar to pre-
involuted thymus [31]. Despite the overwhelming genetic
[32] and molecular evidence pointing to the FOXN1 gene
as the key regulator of thymopoiesis is aging, little is
known on human FOXN1 function and its regulation.
As an initial approach, from consented, young and aging
donors thymic biopsy specimens and a human postnatal
TEC line (hTEC) [33], we tested the expression of genes
that have been reported to be essential for T cell develop-
ment, particularly the inducibility of the FOXN1 gene
expression. Subsequently, we tested the methylation status
of predicted transcriptional regulatory regions of the hu-
man FOXN1 gene inthe cultured human TEC line.
Results
Expression of DLL1, DLL4, FOXN1 and WNT-4 genes in
human thymic samples
Thymic samples were divided into three different groups
according the donor’s age. The groups were created by
considering major hormonal transitions as shown previ-
ously [34]. The “Postnatal” group comprises samples from
5 days-old to 1 year-old (a total of four samples); the
“Child-adolescent” group contains samples whose donors
are 7, 10, 14 and 17 years-old (a total of four samples); the
“Adult” group included samples from donors, 49, 57, 59,
66, 75 and 78 years-old (seven samples total). As repre-
sented in Fig. 1a and b, respectively, the Delta-like 1
(DLL1) and 4 (DLL4) genes presented low relative levels
in the younger groups, showing a significant elevation in
the “Adult” group, while the Forkhead box protein N1
(FOXN1) gene expression was significantly decreasing
from “Postnatal” through “Child-adolescent” to the “Adult”
group (Fig. 1c). It is important to note that age vs. normal-
ized expression levels of FOXN1 do correlate significantly
(see Additional file 1: Figure S1). The wingless-type MMTV
integration site family, member 4 (WNT-4) gene expression
seemed constitutive, not showing remarkable differences
over time (Fig. 1d).
Histology, thymic epithelial organization and FOXN1
protein expression
The “Postnatal” thymic samples, from 5 days-old to 1 year-
old, showed typical morphology, with the surrounding con-
nective capsule, trabeculae, cortical and medullary regions.
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With the exception of occasional individual fat cells
in the interlobular areas, we did not detect thymic
adipose tissue in these samples (Fig. 2a). Cytokeratin
labelling pattern revealed the typical thin mesh dis-
tributed throughout the thymic cortex, and with more
dense medullary TEC (Fig. 2c). In the “Child-adolescent”
group we detected considerable amount of organized
adipose tissue embedded in interlobular areas (See
Additional file 1: Figure S2). It is important to note that
the cortex to medulla ratio is lower, thus the thymic lobes
seem to possess relatively larger medullary areas and over-
all, smaller lobes (See Additional file 1: Figure S2). In the
“Adult” group, intrathymic adipose tissue dominates, and
no well-defined cortical and medullary regions could be
distinguished (Fig. 2b). The cytokeratin organization is
severely altered, and this becomes more profound with
increasing age (Fig. 2d).
Since with qPCR we found significantly lower FOXN1
gene expression in the “Adult” group compared to the
younger groups of thymic samples, we tested and com-
pared the expression of FOXN1 protein in samples from
the “Postnatal” and “Adult” groups by immunofluores-
cence. We observed characteristic nuclear FOXN1 stain-
ing in the “Postnatal” group. FOXN1 positive cells were
distributed in the cortex, although the majority of epi-
thelial cells were negative, suggesting heterogeneity of
thymic epithelium with respect to FOXN1 expression
(Fig. 2e). Surprisingly, no FOXN1 protein expression
Fig. 1 DLL1, DLL4, FOXN1 and WNT-4 gene expression in human thymic samples. Gene expression was assessed by real-time quantitative PCR.
DLL1 (a), DLL4 (b), FOXN1 (c) and WNT-4 (c). The graphs show mean ± SEM of normalized expression values from each group. Difference between
the samples was analyzed through Kruskal-Wallis non-parametric test followed by Dunn’s multiple test. Data was considered statistical significant
when p < 0.05
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was detectable in samples from the “Adult” group, even
though the thymic epithelium was clearly detectable,
typical staining patterns are shown on Fig. 2f.
hTEC cell line, a model of aging thymic epithelium
Recent reports indicate that thymocyte development is in-
duced and supported by Foxn1 transduced mouse fibro-
blast cells that transdifferentiate to functional thymic
epithelium [18]. Thymus derived epithelial cell lines and
primary monolayers of TEC cultures do not induce full
scale T cell development [35, 36], and this may be related
to a decrease of FOXN1 expression [19, 37] by a yet un-
identified mechanisms. A human TEC line (hTEC), which
expresses membrane proteins specific for human TEC
(in vivo), and able to adhere to T cell precursors, imma-
ture and mature naïve T cells was chosen here for further
investigations [33]. In preliminary experiments, we found
no FOXN1 mRNA expression in hTEC cells (Fig. 3d).
Nevertheless, other tested thymic epithelium genes that
are necessary for T cell development were expressed
(Fig. 3e and f). Due to the lacking FOXN1 expression, the
striking gene expression pattern similarity with the aging
human thymus, the hTEC line served as a model of the
aging thymic epithelium here. Using this model we tested
conditions that have been reported to induce FOXN1
expression [19, 37]. First, we prepared three-dimensional
Fig. 2 Histology, thymic epithelial organization and FOXN1 protein expression. Photomicrographs show morphological aspects of thymus samples
from (a) five days (“Postnatal” group) and (b) 57 years-old donors (“Adult” group). Paraffin sections were stained with haematoxilin-eosin stain and
analyzed by light microscopic examination. (4x, objective magnification). c = cortical region; m =medullary region; a = Adipose tissue;
arrow = connective tissue septum. Panels (c) and (d) show cytokeratin staining of “Postnatal” (5 days-old) and “Adult” thymic samples
(57 years-old), respectively. Frozen thymus sections were reacted with specific pan anti-cytokeratin polyclonal rabbit antibody followed
by Alexa-488 conjugated anti-rabbit Ig antibody (green) before visualization in the fluorescent microscope. (20x, objective magnification).
Photomicrographs (e) and (f) show FOXN1 protein expression in thymus cryosections from “Postnatal” (5 days-old) and “Adult” donors
(57 years-old), respectively. In order to demonstrate thymic epithelium associated FOXN1 expression, the sections were first reacted with anti-human
FOXN1 antibody (red) and subsequently double stained with pan anti-cytokeratin antibody (green). (20x, objective magnification)
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(3D) cultures of hTEC (Fig. 3a) and found that both con-
ventional monolayer and 3D hTEC cultures expressed and
maintained epithelial characteristics as ascertained by
cytokeratin expression (Fig. 3a and b, respectively). How-
ever, neither conventional nor 3D cultures expressed
detectable FOXN1 transcripts, despite the fact that the 3D
culture system based on microspherical substrate did
function, since DLL4 and DLL1 transcripts were detect-
able and showed remarkable induction by the 3D culture
conditions (Fig. 3d, e and f). It is worth to note that we
tested T cell development inducing/maintaining capacity of
the hTEC by co-culturing thymocytes, both in monolayer
and in 3D cultures, but we did not observed increased
thymocyte production in the cultures (data not shown).
In thymus-derived primary epithelial cultures, lithium
chloride (LiCl), a glycogen synthase kinase-3β inhibitor
and a mimetic of the canonical WNT-4 signaling path-
way [38], was shown to induce Foxn1 transcription,
which was accompanied by β-catenin translocation to
the nucleus [19]. Here, we tested whether LiCl induced
FOXN1 expression in hTEC line (Fig. 4). Upon exposure
of hTEC cultures to LiCl treatment for 6 h and for 18 h,
characteristic morphological changes were observed,
namely intensive cell spreading at 6 h (Fig. 4b) and over-
growth, apoptotic aggregation of cell clusters at 18 h
(Fig. 4c), with accompanied β-catenin reorganization,
which included detectable β-catenin nuclear transloca-
tion at in the 6 h of culture (Additional file 1: Figure S3).
As LiCl induced the expected biological response in
hTEC, we tested FOXN1expression using immunostain-
ing and RT-PCR. FOXN1 protein expression was not de-
tectable on untreated hTEC (Fig. 4d), in agreement with
the qPCR data showed on Fig. 3c. Upon LiCl treatment,
the FOXN1 gene remained silent, with no detectable
FOXN1 protein in the LiCl-treated hTEC cultures
(Fig. 4e and f) and no detectable transcripts produced in
the control or in LiCl-treated cell cultures (Fig. 4g).
FOXN1 genomic context of candidate CpG methylation
substrate, C20
As the hTEC line was refractive to FOXN1 transcrip-
tional induction, we thought to investigate DNA methy-
lation, a possible epigenetic silencing mechanism, in
hTEC line. Based on reported DNA methylation data
from Encyclopedia of DNA elements (ENCODE) consor-
tium, we first identified several CpG methylation sites,
Fig. 3 hTEC line, a model of aging thymic epithelium: three-dimensional cell culture in cellulose scaffolds. Conventional hTEC monolayer culture
(b) and hTEC 3D culture (c) maintained for four days in cellulose macroporous scaffolds were immunocytochemical staining for cytokeratin with
DAPI nuclear counterstaining. (20x, objective magnification). qPCR detection of FOXN1 (d), DLL4 (e) and DLL1 (f) transcripts, in conventional monolayer
and 3D cultures. Thymic stroma from 5 days-old sample served as control (“Stroma”). Undetectable level of expression is labelled with “*”
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Fig. 4 hTEC line, a model of aging thymic epithelium. WNT signaling pathway induction. Conventional hTEC monolayer cultures stained with
anti-β-catenin monoclonal antibody (green) (a–c) and anti-human FOXN1 (red) (d–f) with DAPI nuclear counterstain: non-treated control (a, d),
LiCl-treated for 6 h (b, e) and 18 h (c, f). (40x objective magnification). FOXN1 staining on a thymic human sample was used as a positive control
(Fig. 4f, insert). In (g) is shown the RT-PCR detection of FOXN1 transcript after treatment with 20 mM of LiCl for 6 and 18 h. Non-treated cultures
and TEC treated with 20 mM of NaCl were used as negative controls. Legend – F: FOXN1 amplification product; F (−): reverse transcriptase reaction
control without enzyme from FOXN1 amplification product; H: HPRT-1 amplification product; H (−): reverse transcriptase reaction control
without enzyme from HPRT-1 amplification product
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potentially involved in transcriptional regulation of the
FOXN1 gene. In the data set, there are 139 candidate
residues for CpG methylation within the FOXN1 gene.
The candidate CpG residues are distributed in the pro-
moter region, in exons 1, 2, 3, 7, 8, 9 and in introns 1, 2,
3, 6, 7 e 8. We chose one candidate region to test differ-
ential methylation: (i) because of overlap with FOXN1
regulatory regions, (ii) the high GC % context, (iii) the
presence of a predicted CpG island (Fig. 5a and b). The
selected region is a 259 bp-sequence located at the first
FOXN1 intron, was termed C20 (Fig. 5a). The C20 re-
gion is close to the predicted FOXN1 promoter and it
satisfies all criteria for being “CpG methylation target”
for gene expression regulation, such as high GC content
and being within a CpG island. Specifically, the C20 se-
quence contains a simple repeat (CCCG)n=3 of 27 bp in-
side a CpG island of 100 bp-s (Fig. 5b, upper panel).
Experimental data from ENCODE demonstrated that
C20 is located within regulatory regions defined by his-
tone modifications and it is included in a DNA-binding
site cluster for RNA polymerase and the zinc-finger pro-
tein CTCF (CCCTC-binding factor) (Fig. 5b). There are
13 potential CpG methylation sites in this genomic se-
quence (Fig. 5b, low panel). Remarkably, as deduced
from the ENCODE database [39], 8 of the 13 CpG cyto-
sine residues show differential methylation pattern with
respect to FOXN1 expressing human skin [25, 40] and
FOXN1 non-expressing human leukocytes [41] as shown
on Fig. 5c and d, respectively.
FOXN1/C20 region CpG methylation status of hTEC line
We tested CpG methylation status of the 13 cytosine nu-
cleotides present in the C20 sequence by bisulfite con-
version, followed by PCR fragment cloning and DNA
sequencing (See Additional file 1: Figure S4). Methyla-
tion status deduced from sequence analysis of 10 inde-
pendent clones of the C20 region of hTEC cell line
resembles of the FOXN1 non-expressing skin, suggesting
that at least in the case of hTEC (Fig. 5e and f), CpG
methylation within the C20 region correlates with the
observed lack of expression and resistance to induction.
Discussion
Immunosenescence is a physiological process character-
ized by the decline of both adaptive and innate immune
functions [42]. The decreased ability to respond to anti-
gens, at least in human, is thought to be the result of de-
creasing naïve T cell export that ultimately limits
peripheral T cell repertoire in adults [43]. However,
maintenance of naïve T cell repertoire in the periphery is
thought to involve homeostatic regulation of prolifera-
tion [14, 44, 45]. Naïve T-cells derive from the thymus,
however, histological signs of thymic involution are evi-
dent already at the first year of life [8]. As the organ
ages, the thymic interstitium and ultimately intrathymic
TEC areas are infiltrated by adipose tissue and peripheral
lymphoid cells resulting in decreased thymopoiesis, even-
tually limiting the peripheral naïve T cell repertoire [16].
Little is known about the molecular mechanisms under-
lying thymic involution. Current reviews in the literature
disagree whether thymic involution is organ autonomous,
or is it due exclusively to decreasing function of TECs, or,
and in addition, whether it involves changes in bone mar-
row derived stem cell activity and migration [14, 46]?
To address molecular mechanisms involved in human
thymic involution during aging, first we tested gene ex-
pression levels of candidate genes in thymic biopsy spe-
cimen from days-old 5 to 78 years-old (n = 15) from
consented cardiac surgery patients and in a human TEC
line (hTEC). We choose DLL1, DLL4, FOXN1 and
WNT4 genes for the analysis as these genes have been
reported to be necessary for inducing intrathymic T cell
development in mouse models [17, 36, 47, 48]. Particu-
larly, FOXN1 was selected because of reports indicating
reduced expression in the ageing mouse thymus [26]
and because recently, Bredenkamp and co-workers
(2014) [18] showed that mouse embryonic fibroblasts
transfected with inducible mouse Foxn1 support T cell
development in vitro and in vivo. Moreover, critical
pathways for thymic development involve NOTCH
ligands and receptors. In mouse models it was demon-
strated that DLL1, DLL4, Jagged-1 (JAG-1) e JAG-2
ligands are expressed on TEC with their receptors
expressed on thymocytes [49–51]. It is well established
that DLL4 produced by TEC is responsible for T cell
lineage commitment, being necessary for the mainten-
ance of the three dimensional architecture of the thymic
microenvironment [37, 47, 52]. Despite the broad range
of studies on NOTCH and its ligands, little is known
about their participation in thymic involution, especially
in the human thymus. In addition to the NOTCH family
of ligands, we also evaluated WNT-4 gene expression.
WNT-4 glycoprotein is secreted and it is produced both
by TEC and thymocytes [53]. In a mouse model, WNT-4
was shown to play important role in organ development,
T lymphocyte differentiation, and it was also associated
with thymic involution [27, 48, 54, 55]. The WNT-4 glyco-
protein also operates on TEC through induction of Foxn1
expression in the mouse [19]. The decrease in the expres-
sion of FOXN1 has been studied as a hallmark of thymic
senescence, although nothing is known on its expression
in the human thymus during aging.
Our quantitative PCR gene expression experiments in-
dicate that DLL1 and DLL4 are constitutively expressed
in the human thymus, with a significant increase in the
“Adult” group of thymus donors. In contrast, studies in
experimental mouse models showed decrease in expres-
sion of Dll4 in cortical TEC from old animals [31]. Since
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Fig. 5 FOXN1 genomic context, potential methylation substrate C20 and CpG methylation status on hTEC. Panel (a) shows the genomic localization
of C20 region on FOXN1 gene and (b) (upper panel) presents the relative GC content, CpG island prediction, repetitive region (simple), histone
modifications and transcriptional factor binding sites on C20 region. Histone modifications and transcriptional factor binding sites were evaluated
by ENCODE consortium laboratories using chromatin immunoprecipitation followed by DNA sequencing [39]. The CpG island was predicted using
MethPrimer web-based software [68] and the repetitive region was obtained in the RepeatMasker database [74]. Lower panel in (b) shows the C20
nucleotide sequence. Above is the normal genome sequence and below is the bisulfite converted sequence. In red is presented the CpG residues.
The arrows (> and <) indicate the forward and reverse specific bisulfate primers used for sequencing. The CpG island is underlined in black and the
yellow label marks the repetitive region. CpG methylation status on C20 region was obtained for FOXN1expressing human skin (c) and
FOXN1 non-expressing human leukocytes (d) from the ENCODE database on DNA Methylation by Reduced Representation Bisulfite Sequencing data
provided by ENCODE/HudsonAlpha laboratory. FOXN1 gene graphic representation and DNA elements regulation were adapted from UCSC genome
browser from the human genome assembly hg19 using “ENCODE regulation” track features [39, 67]. The graph in (e) represents the percentage of
CpG methylation, for each residue, and in hTEC cell line clone sequences, while the diagrams in (f) show the 13 CpG-s presented as lollipop diagrams,
where the methylated residue is shown in black circles, while the non-methylated residue is in open circles. Percent values were obtained after
multiple sequence alignment using ClustalW algorithm followed for methylated CpG quantification using BiQ analyzer software
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TEC isolation in our samples was not possible, it is rea-
sonable to think that the high expression of DLL1 and
DLL4 observed in “Adult” group is related to the presence
of adipocytes in these samples. In fact, DLL4 expression
has been reported in adipose tissue from human and ani-
mals subjected to high-fat diet [56]. Nevertheless, due to
their increasing expression, DLL1 and DLL4 are not likely
to limit human thymopoesis. Similarly to the NOTCH
ligands, WNT-4 gene is transcriptionally active in the
human thymus in all tested groups, with a slight increase
in expression in the “Child-adolescent” thymus samples.
Although gene expression studies from whole organ are
not suitable to address cell type specific expression, we
suggest that the soluble factor, WNT-4, may be present in
the aging thymus, thus it is not likely to limit thymopoetic
activity either.
For the first time, we report here a striking three-fold
decrease of FOXN1 expression over time in the human
thymus, when comparing the “Postnatal” group with the
“Adult” group. In fact, the decrease of TEC associated
expression levels may be markedly higher, as due to the
relatively lower lymphocyte content of the aging thymus,
the relative abundance of TEC is increasing. We thus sug-
gest that FOXN1 expression may limit thymopoiesis and
its reduced expression may be responsible for thymic sen-
escence. This notion is strongly supported by the fact that,
although TECs are present in the samples of typical
morphologically-defined aging thymus, FOXN1 protein
were not detected in epithelial cells. The notion is also in-
line with recent reports indicating that inducible Foxn1
expression in mouse embryonic fibroblasts mediates
trans-differentiation to functional TEC [18], suggesting
that, at least in mice, FOXN1 is necessary and seemingly
sufficient to induce thymopoiesis. Key role of FOXN1 gene
in human thymopoiesis is likely as the phenotype of the
FOXN1 null mutant humans [25, 57] is very similar to that
of the nude phenotype of homozygous Foxn1 mutant mice
and rats [22, 24]. Moreover, thymic histology of Foxn1
homozygous mutants strongly resembles that of thymic
samples from aging individuals [28, 29].
To model age-related changes, we tested a human thy-
mus derived epithelial cell line, hTEC, for expression of
FOXN1, DLL1 and DLL4 genes. Although, the hTEC
does bind to early thymocyte subsets, it does not induce
or support full scale T cell development [33]. As we
found no detectable FOXN1 expression in cultured
hTEC (while DLL1 and DLL4 gene expression were def-
initely detected) we tested whether hTEC cells would
respond to stimuli reported to induce FOXN1 expres-
sion. To this end, we used 3D culture conditions shown
to induce FOXN1 expression in hTEC cultures [37] and
LiCl treatment, which was also reported to induce
downstream canonic pathway of WNT signaling, includ-
ing Foxn1 expression induction in murine TEC [19]. The
hTEC cell line did not respond to the tested specific stimu-
latory signals by increasing FOXN1 expression. We there-
fore suggest that although WNT-4 may regulate FOXN1
expression, it requires FOXN1 gene to be responsive for
inductive signaling by WNT-4. Thus hTEC is seemingly
resistant to FOXN1-inducing stimuli. Among others, such
resistance could be the result of transcriptional silencing,
mediated by epigenetic regulatory mechanisms.
One of the most important epigenetic mechanisms
that is often involved in transcriptional regulation during
development is CpG methylation [58]. To investigate the
methylation status of CpG residues in the FOXN1 gene
in the hTEC, we tested a candidate regulatory region (we
named C20) by bisulfite conversion followed by DNA
sequencing. In the C20 candidate region FOXN1 ex-
pressing skin cells [25, 39, 40] show minimal methyla-
tion in 8 of the 13 candidate CpGs of the C20 region,
while FOXN1 non-expressing leukocyte [39, 41] is highly
methylated. We could observe that hTEC line DNA
exhibits remarkably elevated methylation compared to
skin DNA (from the ENCODE database). Overall methy-
lation is decreasing with age, and we have detected this
in the human thymic biopsy samples (ongoing studies;
see Additional file 1: Figure S5) consistently with the
age-dependent demethylation of CpG-s that has been re-
ported in many tissues [59–61]. Hypermethylation of the
C20 segment of the hTEC provides a strong clue sup-
porting our hypothesis, namely that hypermethylation
may gradually silence the FOXN1 ultimately leading to
decreased thymopoesis.
Conclusions
For the first time in human thymus we show that FOXN1
expression decreases with age. Considering the central
role of FOXN1 in thymopoesis we suggest that mechan-
ism affecting FOXN1 expression regulation may be critic-
ally involved in thymic senescence. To support the notion
we show that FOXN1 gene in hTEC line is resistant to
transcriptional induction that mimic physiological condi-
tions. With respect to the hTEC line, our data supports
the hypothesis that resistance of the FOXN1 gene to
physiological and chemical stimulatory signals may be
mediated by an epigenetic mechanism, namely CpG
methylation of specific regulatory regions(s) like C20. Al-
though, the depth of the experiments and the heteroge-
neous tissue are severely limiting our conclusions, as a
working hypothesis for future experimentation, we suggest
that developmentally regulated CpG methylation of
FOXN1 may be a critical molecular mechanism behind
thymic senescence and age related immunodeficiency. As
our hypothesis needs further support from more access-
ible and specific rodent and in-vitro models, we plan to
continue towards further understanding of epigenetic
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mechanisms behind thymic senescence with the hope that
we may open avenues for therapeutic modulation via
small molecule drugs.
Methods
Cell culture
The human TEC line (hTEC) was originally obtained
from an infant thymus by primary explant culture and
limiting dilution cloning [33], however since its deriv-
ation the cell lines has been passaged over 100 times. It
has been kindly provided by Dr. Maria Luiza Toribio
(Universidad Autonoma de Madrid, Madrid, Spain).
These cells were shown to express cytokeratins and sev-
eral surface proteins, such as CD71, CD40, MHC I
(HLA-ABC), MHC II (HLA-DR)low, ICAM-1, LFA-3,
CD44, integrin-type ECM receptors including VLA-4,
VLA-5 and VLA-6 [32, 62]. Cells were cultured in 10 %
fetal calf serum (Cultilab, São Paulo, Brazil) supple-
mented RPMI 1640 medium (Mediatech, Virginia, USA)
at 37 °C in a 5 % CO2 atmosphere. Alternatively, these
cells were cultured in three-dimensional cell culture system
using macroporous cellulose microcarriers (Cytopore™,
Asaki Kasei Medical Co., GE Healthcare, Japan) as de-
scribed previously [63] with some modifications. Briefly,
100 μL of phosphate-buffered saline (PBS)-hydrated macro-
porous cellulose microcarriers were colonized with cells in
a volume of the 2x105 cells under nitrocellulose membrane
from Transwell™ inserts (Costar, Corning Incorporated,
USA) and cultured for 4 days with complete medium at
37 °C in a 5 % CO2 atmosphere. Under these conditions,
the cells were allowed to grow in 3D environment (Fig. 3a).
Sample collection and histology
Thymus samples were obtained from consented paediatric
and adult patients undergoing cardiac surgery at the
György Gottsegen National Institute for Cardiology,
(Semmelweis University, Budapest, Hungary) and from
the Department of Cardiac Surgery of the Clinical Center,
University of Debrecen (Debrecen, Hungary) under a
protocol approved by the Hungarian Ethics Committee
for Science and Research (11739-/2014/EKU 107/2014.)
and the local institutional review boards. Patients’ blood
counts were in the normal range in all cases as this is pre-
requisite condition for selected eletive surgeries. Fresh
thymus fragments were cleaned, washed in PBS and fixed
in neutral buffered formalin for routine histological exam-
ination. Additional 3×3×3 mm fragments were snap fro-
zen and kept at −80 °C until use.
Lithium chloride treatment
hTEC line were cultured under standard conditions with
complete medium for two days, and then treated with
20 mM of lithium chloride (LiCl) for 6 and 18 h as pre-
viously described to induce the WNT signaling pathway
[19, 64]. Non-treated cells and sodium chloride (NaCl)-
treated cells were used as negative controls. After treat-
ment, cells were used for RNA isolation or fixed with
100 % methanol for imunofluorescence staining.
Immunofluorescence
Immunofluorescence assays were used to evaluate
FOXN1, cytokeratin and β-catenin protein expression in
thymus samples and hTEC line cultured under various
conditions. Briefly, thymic frozen sections fixed in
acetone, and hTEC cultures fixed with 100 % methanol,
were re-hydrated in PBS and incubated for 30 min with
PBS containing 1 % bovine serum albumin to block un-
specific binding. Next, the specimens were incubated
with primary antibodies specific for human FOXN1
(donkey IgG, 1:50; Santa Cruz Biotechnology, Heidel-
berg, Germany), pan-cytokeratin (rabbit IgG, 1:100;
DAKO, Aligent Technologies, Glostrup, Denmark) or
human β-catenin (mouse monoclonal antibody, IgG1,
1:30; Santa Cruz Biotechnology, Heidelberg, Germany)
for 1 h and 30 min at room temperature in a humidified
chamber. After washings with PBS, the slides were incu-
bated with corresponding fluorochrome-labeled second-
ary antibody for 45 min at room temperature, in a dark
humidified chamber. Secondary reagents were: goat anti-
rabbit (1:400; Molecular Probes, Life Technologies), goat
anti-mouse (1:400; Molecular Probes, Life Technologies)
and donkey anti-goat (1:400; Invitrogen). Next, after
washing in PBS, the specimens were mounted for exam-
ination in the fluorescence microscope, a Zeiss Axio
Imager A2 (Carl Zeiss, Oberkochen, Germany) equipped
with Axio Vision Release 4.8.2 software (Zeiss). Negative
controls in which primary antibodies were replaced by
unrelated immunoglobulins or in which the secondary
antibody was used alone did not generate significant
immunolabeling.
RNA isolation, cDNA synthesis and PCR assays
Total RNA from thymus samples and hTEC line were
purified by phenol-chloroform and used as templates for
first strand cDNA synthesis followed by gene expression
analysis via RT-PCR and quantitative PCR assays as fol-
lows. Small fragments of frozen thymi were homoge-
nised with tissue homogenizer (T10 Basic, IKA®) in 1 ml
of Trizol (TriReagent®, Molecular Research Center, Ohio,
USA) whereas hTEC cultured in conventional mono-
layers or in 3D scaffolds were released from the substrate
with trypsin/EDTA treatment for 10 min, centrifuged,
washed in PBS and homogenized with 1 ml of Trizol
(TriReagent®, Molecular Research Center, Ohio, USA).
After homogenization, RNA was purified according
manufacturer’s instructions. Total RNA concentration
and purity were determined by the ratio of absorb-
ance readings at 260 vs. 280 nm on NanoDrop ND
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2000 spectrometer (Thermo Scientific, Delaware, USA).
Up to 2 micrograms of total RNA were used to synthesize
cDNA using high capacity cDNA reverse transcription kit
(Applied Biosystems, California, USA) following manufac-
turer’s protocol. Quantitative PCR and RT-PCR reactions
were performed using oligonucleotides previously de-
scribed in the literature or specifically designed based on
the target gene sequences reported in NCBI GenBank
using the Primer3 software from the NCBI/BLAST plat-
form [65]. Specific sequences are shown in Table 1. For
RT-PCR reactions, eight microliters of diluted cDNA (1:5)
were mixed with nuclease-free water, 1.5 millimolar of
MgCl2, 1X Taq polimerase buffer, 0.025 millimolar of
dNTPs, 0.05 units per microliter of Taq polimerase and
0.5 micromolar of each primer in a 50 μl of total volume
(all from Applied Biosystems, California, USA except the
nuclease-free water and primers). The cycling conditions
were as follows: initial denaturation at 94 °C for 2 min,
followed by 30 cycles with denaturation 94 °C for 30 s, an-
nealing at 60 °C for 30 s, and elongation at 72 °C for 30 s
using the A&B thermocycler 2720 (Applied Biosystems,
California, USA). Ten microliters from each PCR reaction
were run on 2 % agarose gels at 90 V. The PCR products
were visualized under UV light using ethidium bromide
staining. The quantitative PCR reactions were performed
using 5 μl from 5-fold diluted cDNA sample mixed with
Maxima SYBR Green/ROX qPCR Master Mix (Thermo
Scientific, California USA) containing specific oligonucle-
otides (0.3 micromolar; Table 1) in microwells of optical
384-well plates according to manufacturer’s protocol. All
samples were run in triplicates. The reactions were run in
the ABI PRISM® 7900HT sequence analyser instrument
(Applied Biosystems, California, USA) with Sequence
Detector System 2.2 Software following three-step cycling
protocol with 95 °C for 10 min for initial denaturation;
95 °C for 15 s to denaturation; 60 ° C of 30 s to elongation
and 30 s of 72 °C to extension. After amplification, the Ct
values were used to obtain normalized expression values
as previously described [66].
DNA Isolation and bisulfite treatment
Genomic DNA samples were isolated from the hTEC line
using the Wizard® Genomic DNA Purification Kit
(Promega, Wisconsin, USA) according to the manufac-
turer’s instructions. After isolation, DNA concentration
and purity were determined by the ratio of absorbance
readings at 260 and 280 nm on NanoDrop ND 2000 spec-
trometer (Thermo Scientific, Delaware, USA). Two micro-
grams of DNA were used to perform bisulfite treatment
using Epitect Bisulfite Kit (Qiagen, Hilden, Germany) fol-
lowing the supplier’s instructions. After reaction, the con-
verted DNA was purified using silica columns (EpiTect
spin columns, Qiagen, Hilden, Germany), eluted in RNAse
and DNAse free water and keep in −20 freezer until use.
DNA Methylation analysis
Candidate regulatory sequences for CpG methylation
were selected from the FOXN1 gene using features of
the University of California Santa Cruz (UCSC) genome
browser (UCSC ID: uc010crm.3; [67]). For selection, in
addition to known features relevant to probable CpG
methylation, we used experimental data reported in
UCSC genome browser, namely the DNA methylation,
by reduced representation bisulfite sequencing performed
by the Encyclopedia of DNA Elements (ENCODE) con-
sortium [39]. Selected regions were exploited as targets to
design bisulfite-treated DNA specific oligonucleotides
using the MethylPrimer Express v 1.0 software (Applied
Biosystems) and the web-based software MethPrimer [68].
Both programs have algorithms for primer design specific
for bisulfite-treated DNA, according the criteria described
by Li and Dahiya (2002) [68]. For bisulfite sequencing, iso-
lated DNA from hTEC line were converted with sodium
bisulfite using Epitect Bisulfite kit (Qiagen, Hilden,
Germany) as described above. The selected candidate se-
quence (Fig. 5a and b) was amplified with specific primers
for FOXN1/C20 region (F: GTTTAGGGTGAGTTAGG
TAGGGATAG; R: AAAAACAAATTTCTAACTCTAAA
AATAAAT). The PCR products were cloned in pGEM-T
Table 1 Forward and reverse primer sequences used on the quantitative PCR and RT-PCR assays
Target Sequence forward (5'-3') Sequence reverse (5'-3') Amplicon size (pb) Reference
FOXN1 (NM_003593.2) TCCCTCACTCACTGACTTCG (1628–1647) GTGGCATCGAAGATGATGTC (1746–1727) 119 [72]
DLL1 (NM_005618.3) TGCAACCAGGACCTGAACTA (1323–1342) CTCCGTTCTTACAAGGGCTG (1491–1472) 163 *
DLL4 (NM_019074.3) CAGAGTGTCGGATATCAGCG (2288–2307) CTCCTGCCTTATACCTCCGT (2402–2383) 115 *
WNT-4 (NM_030761.4) CAGCAGAGCCCTCATGAACC (647–666) GCCAGCACGTCTTTACCTCACA (768–747) 122 [73]
HPRT-1 (NM_000194.2) CCTGGCGTCGTGATTAGTG (183–201) TCGAGCAAGACGTTCAGTCC (320–301) 138 *
TFRC (NM_001128148.1) CTAGTGTTCTTCTGTGTGGCAGTT (115–138) ACAATGGTTCTCCACCAAACAAG (197–175) 83 *
RPL13A (NM_001270491.1) CGGACCGTGCGAGGTATGCT (244–263) AGCAGGAACCACCATCCGCT (366–347) 123 *
HPRT-1 (hypoxanthine phosphoribosyltransferase 1), TRFC (transferrin receptor) and RPL13A (ribosomal protein L13a) were used as control housekeeping genes.
(*)Designed using the software Primer3 [37]. FOXN1: forkhead box N1; DLL1: Delta-like 1 (Drosophila); DLL4: Delta-like (Drosophila) 4; WNT-4: wingless-type MMTV
integration site family, member 4.
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plasmid (pGEM®-T Easy Vector System I; Promega,
Wisconsin, USA) and the inserts were sequenced using
BigDye® Terminator Cycle Sequencing Kit (Applied Biosys-
tems, California, USA) using forward or reverse PCR
primers. The reactions were performed in ABI3730xl DNA
analyzer (Applied Biosystems, California, USA) at the
Fiocruz DNA sequencing platform (Rio de Janeiro, Brazil).
Traces were analysed with BioEdit: Sequence Alignment
Editor v. 7.2.5 (Ibis Biosciences, Califorina, USA), aligned
with ClustalW v1.83 [69] and submitted to CpG quantifica-
tion using BiQ analyzer v2.00 [70]. Percent methylation,
with respect to each individual CpG, and the global average
percentage methylation per each candidate sequences were
displayed. For methylation call we used >90 % conversion
threshold. Lollipop diagrams were made per samples using
Quantification Tool for Methylation Analysis (QUMA)
web software [71].
Statistical analyses
To test the probability of significant differences among the
different study groups, the data obtained were analyzed
GraphPad Prism software version 5.00 (GraphPad Prism
Software, Inc.) using the non-parametric one-way ANOVA
Kruskal-Wallis test, followed by Dunn’s post-test. The
values were represented by the mean ± standard error of
the mean (SEM) and considered significant when p ≤ 0.05.
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